NCT00299936View on ClinicalTrials.gov

Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

Not specified

Conditions
Chronic Hepatitis C
Interventions
DRUG

Ribavirin, PEG-Intron

Sponsors

Collaborators (1)

Schering-Plough
All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT00299936 - Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects | Biotech Hunter | Biotech Hunter